Video

Samsung Biologics Capacity Update April 2025: Large Molecule Development

Taking a biologic drug candidate from discovery to commercialization is a long, cost-intensive process. Therefore, leveraging expertise from a reliable CDMO with the right capability and resources can streamline the drug development journey.

Samsung Biologics offers end-to-end solutions taking your molecule seamlessly from sequence to IND. Utilizing advanced technical platforms, technical knowledge, and diverse and flexible capacity, Samsung Biologics is helping clients reduce the time and costs of biologic development, while paving a smooth transition from clinical to commercial manufacturing.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Samsung Biologics